Multiple sclerosis and Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of Neurology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.21240PMID 17924575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The immunology of inflammatory demyelinating disease

  2009cited by this paper
• Extracellular Hmgb1 Functions as an Innate Immune‐Mediator Implicated in Murine Cardiac Allograft Acute Rejection

  2007cited by this paper
• Journal of Neuroinflammation BioMed Central

  2007cited by this paper
• Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis

  2007cited by this paper
• Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry

  2007cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007cited by this paper
• Inflammatory processes in Alzheimer's disease.

  2007cited by this paper
• The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production.

  2006cited by this paper
• A View on Early Diagnosis of Dementias from Neuropathology

  2006cited by this paper
• The dementias : early diagnosis and evaluation

  2006cited by this paper
• Gene expression changes by amyloid β peptide‐stimulated human postmortem brain microglia identify activation of multiple inflammatory processes

  2006cited by this paper
• Microglial senescence: does the brain's immune system have an expiration date?

  2006cited by this paper
• Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?

  2006cited by this paper
• Negative regulation of leucocyte functions by CD33-related siglecs.

  2006cited by this paper
• Interleukins, inflammation, and mechanisms of Alzheimer's disease.

  2006cited by this paper
• AM-3K, an Anti-macrophage Antibody, Recognizes CD163, a Molecule Associated with an Anti-inflammatory Macrophage Phenotype

  2006cited by this paper
• Neocortical neuronal, synaptic, and glial loss in multiple sclerosis

  2006cited by this paper
• The microglial "activation" continuum: from innate to adaptive responses

  2005cited by this paper
• Macrophage receptors and immune recognition.

  2005cited by this paper
• Cortical demyelination and diffuse white matter injury in multiple sclerosis.

  2005cited by this paper
• Grey Matter Pathology in Multiple Sclerosis

  2005cited by this paper
• Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.

  2005cited by this paper
• McAlpine's Multiple Sclerosis

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis

  2004cited by this paper
• Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.

  2004cited by this paper
• Microglial activation facilitates A B plaque removal following intracranial antiA B antibody administration

  2004cited by this paper
• Inflammatory processes in Alzheimer's disease.

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration

  2003cited by this paper
• The role of nitric oxide in multiple sclerosis.

  2002cited by this paper
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in rasmussen's encephalitis

  2002cited by this paper
• Perspective on antigen processing and presentation

  2002cited by this paper
• The allograft inflammatory factor‐1 family of proteins

  2002cited by this paper
• Cloning and Characterization of Human Siglec-11

  2002cited by this paper
• Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.

  2001cited by this paper
• Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

  2001influential reference
• Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

  2001cited by this paper
• Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.

  2001cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Relapses and progression of disability in multiple sclerosis.

  2000cited by this paper
• Interleukin 1 in the brain: biology, pathology and therapeutic target.

  2000cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35].

  1999cited by this paper
• Cortical lesions in multiple sclerosis.

  1999influential reference
• Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination

  1998cited by this paper
• The role of nitric oxide in multiple sclerosis

  1997cited by this paper
• Pathological τ proteins in postencephalitic parkinsonism: Comparison with Alzheimer's disease and other neurodegenerative disorders

  1997cited by this paper
• Glucose transporter glut 5 expression in microglial cells

  1997cited by this paper
• Macrophage membrane molecules: markers of tissue differentiation and heterogeneity.

  1996cited by this paper
• Monocyte/macrophage differentiation in early multiple sclerosis lesions

  1995cited by this paper
• Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population

  1994cited by this paper
• Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder.

  1994cited by this paper
• Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

  1991cited by this paper
• Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism

  1983cited by this paper

• Improvement of Parkinson’s Disease Symptoms by Butylphthalide Through Modulation of Microglial Activation

  2025influential citation
• Glial Cytokine and Metabolic Networks in Progressive Multiple Sclerosis: From Pathophysiology to Biomarkers and Therapeutic Strategies

  2025cites this paper
• Activated Peripheral CD8 + T Lymphocytes Inhibit the Proliferation of Hippocampal Neural Stem Cells via the IFN‐γ/JAK/STAT Signaling Pathway

  2025cites this paper
• Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers

  2025cites this paper
• Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS

  2025cites this paper
• Molecular pathway of neurodegenerative diseases: Allopathic and herbal approaches

  2025cites this paper
• Circadian Rhythm, Microglia-Mediated Neuroinflammation, and Alzheimer's Disease.

  2025cites this paper
• Astaxanthin as an adjunct therapy in Alzheimer’s disease and multiple sclerosis: neuroprotective mechanisms and future perspective

  2025cites this paper
• The Complementary Role of Morphology in Understanding Microglial Functional Heterogeneity

  2025cites this paper
• Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes

  2025cites this paper
• Is there a link between multiple sclerosis and Alzheimer disease? A critical note.

  2025cites this paper
• Tau in Multiple Sclerosis: A Review of Therapeutic Potential

  2025cites this paper
• Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review

  2024cites this paper
• A series of indole-derived γ-hydroxy propiolate esters as potent anti-inflammatory agents: Design, synthesis, in-vitro and in-vivo biological studies.

  2024cites this paper
• Heterogeneity of mature oligodendrocytes in the central nervous system

  2024cites this paper
• Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex

  2024cites this paper
• Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients

  2024cites this paper
• The ageing central nervous system in multiple sclerosis: the imaging perspective

  2024cites this paper
• The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder

  2023cites this paper
• Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older‐Onset Multiple Sclerosis

  2023influential citation
• Exploring Shared Genetic Signatures of Alzheimer’s Disease and Multiple Sclerosis: A Bioinformatic Analysis Study

  2023cites this paper
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

  2023cites this paper
• MiR-107 Activates NF- κ B versus A β Analysis of the regulatory effect of 1-42 induced apoptosis in Alzheimer's disease cells.

  2023cites this paper
• Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes

  2023cites this paper
• Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus

  2023cites this paper
• Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation

  2022cites this paper
• Cognitive Decline in Older People with Multiple Sclerosis—A Narrative Review of the Literature

  2022cites this paper
• Association of autoimmune diseases with Alzheimer's disease: A mendelian randomization study.

  2022cites this paper
• A perspective on causality assessment in epigenetic research on neurodegenerative disorders

  2022cites this paper
• Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status

  2022cites this paper
• Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?

  2022cites this paper
• A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics

  2022cites this paper
• Tissue donations for multiple sclerosis research: current state and suggestions for improvement

  2022cites this paper
• Immunosenescence in Neurological Diseases—Is There Enough Evidence?

  2022cites this paper
• Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.

  2021cites this paper
• System biology and bioinformatics pipeline to identify comorbidities risk association: Neurodegenerative disorder case study

  2021cites this paper
• One Brain—All Cells: A Comprehensive Protocol to Isolate All Principal CNS-Resident Cell Types from Brain and Spinal Cord of Adult Healthy and EAE Mice

  2021cites this paper
• Is There Any Evidence of Monocytes Involvement in Alzheimer’s Disease? A Pilot Study on Human Postmortem Brain

  2021cites this paper
• Diagnosis of Alzheimer's disease and related dementia among people with multiple sclerosis: Large cohort study, USA.

  2021cites this paper
• Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease

  2021cites this paper
• Kurt Jellinger 90: his contribution to neuroimmunology

  2021cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer Disease Pathology: A Case Series

  2021cites this paper
• Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis

  2020cites this paper
• CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?

  2020cites this paper
• Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis

  2020influential citation
• Differential Diagnosis of Cognitive Decline in Elderly Individuals With Multiple Sclerosis.

  2020cites this paper
• Role of tissue Transglutaminase in glial cell processes involved in multiple sclerosis

  2020cites this paper
• Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis

  2020cites this paper
• Management of Multiple Sclerosis Symptoms and Comorbidities.

  2019cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer's disease: A review.

  2019cites this paper
• Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain

  2018cites this paper
• Neuropharmacology in Flux: Molecular Modeling Tools for Understanding Protein Conformational Shifts in Alzheimer’s Disease and Related Disorders

  2018cites this paper
• Progress in understanding the pathophysiology of multiple sclerosis.

  2018cites this paper
• The Gut-Microglia Connection: Implications for Central Nervous System Diseases

  2018cites this paper
• The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening

  2017cites this paper
• Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier

  2017cites this paper
• Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

  2017cites this paper
• Does Infection Cause Alzheimer’s?

  2017cites this paper
• N-3 Polyunsaturated Fatty Acids and Neuroinflammation in Alzheimer's Disease

  2017cites this paper
• The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer's disease.

  2017cites this paper
• Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice

  2016cites this paper
• Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients

  2016cites this paper
• Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings

  2016cites this paper
• The meninges: new therapeutic targets for multiple sclerosis.

  2015cites this paper
• Pathological differences between white and grey matter multiple sclerosis lesions

  2015cites this paper
• Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space

  2015cites this paper
• Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals

  2015cites this paper
• Lowered Levels of Carbonyl Proteins after Vitamin B Supplementation in Patients with Mild Cognitive Impairment and Alzheimer's Disease

  2015cites this paper
• Analyzing dendritic spine pathology in Alzheimer’s disease: problems and opportunities

  2015cites this paper
• Chronic meningeal inflammation as a cause of cortical grey matter pathology in multiple sclerosis

  2014cites this paper
• Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.

  2014cites this paper
• Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron

  2014cites this paper
• Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter

  2014cites this paper
• Oligodendrocyte‐microglia cross‐talk in the central nervous system

  2014cites this paper
• Prominence of Central Sphingosine-1-Phosphate Receptor-1 in Attenuating Aβ-Induced Injury by Fingolimod

  2014cites this paper
• Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

  2014cites this paper
• Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis

  2014cites this paper
• Alzheimers Disease: Know The Risk Factors.

  2014cites this paper
• Role of meningeal inflammation in cortical pathology and disease progression of multiple sclerosis

  2013cites this paper
• Grey matter lesions in MS

  2013cites this paper
• Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.

  2013cites this paper
• Investigation of the pathophysiology of progression in multiple sclerosis: studies on cerebrospinal fluid biomarkers

  2013cites this paper
• Review series on immune responses in neurodegenerative diseases: oligodendrocyte-microglia cross-talk in the central nervous system

  2013cites this paper
• Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

  2013cites this paper
• In vivo uptake of β-amyloid by non-plaque associated microglia.

  2012cites this paper
• Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

  2012cites this paper
• Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model

  2012cites this paper
• Sujatha Kannan Palsy in a Rabbit Model Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral

  2012cites this paper
• Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

  2012cites this paper
• Imaging of Microglia in Patients with Neurodegenerative Disorders

  2012influential citation
• Clas-amyloid metabolism in multiple sclerosis β Cerebrospinal fluid biomarkers of

  2012cites this paper
• Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy

  2012cites this paper
• Characterization of the inflammatory response to solid cancer metastases in the human brain

  2012cites this paper
• Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy

  2012cites this paper
• BRAIN Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis

  2012cites this paper
• Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

  2011cites this paper
• Neuropathology of Alzheimer's Disease and its Variants

  2011cites this paper
• Inflammation, demyelination, and degeneration - recent insights from MS pathology.

  2011cites this paper
• Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.

  2011influential citation
• Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis

  2011cites this paper